Status: current, Primitive. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2096501000168117 | Candesartan HCTZ 32/25 (Apotex) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2096511000168119 | Candesartan HCTZ 32/25 (Apotex) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Candesartan HCTZ 32/25 (Apotex) | Is a | trade product | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Candesartan HCTZ 32/25 (Apotex) tablet | Is a | True | Candesartan HCTZ 32/25 (Apotex) | Inferred relationship | Some | |
Candesartan HCTZ 32/25 (Apotex) tablet, 30 | has TP | True | Candesartan HCTZ 32/25 (Apotex) | Inferred relationship | Some | |
Candesartan HCTZ 32/25 (Apotex) tablet, 7 | has TP | True | Candesartan HCTZ 32/25 (Apotex) | Inferred relationship | Some | |
Candesartan HCTZ 32/25 (Apotex) tablet, 30, blister pack | has TP | True | Candesartan HCTZ 32/25 (Apotex) | Inferred relationship | Some | |
Candesartan HCTZ 32/25 (Apotex) (candesartan cilexetil 32 mg + hydrochlorothiazide 25 mg) tablet, 7 tablets, blister pack (containered trade product pack) | has TP | True | Candesartan HCTZ 32/25 (Apotex) | Inferred relationship | Some |
Reference Sets